Download PDF
CC BY 4.0 · The Arab Journal of Interventional Radiology 2025; 09(01): 001-005
DOI: 10.1055/s-0044-1791222
Review Article

Early and Midterm Outcomes of Percutaneous Arteriovenous Fistula Creation

Ahmed Kamel Abdel Aal
1   Department of Diagnostic and Interventional Imaging, University of Texas Health Science Center at Houston, Houston, Texas, United States
,
Juri Bassuner
1   Department of Diagnostic and Interventional Imaging, University of Texas Health Science Center at Houston, Houston, Texas, United States
,
Husameddin El Khudari
2   Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama, United States
,
Reema F. Alrasheed
1   Department of Diagnostic and Interventional Imaging, University of Texas Health Science Center at Houston, Houston, Texas, United States
,
Shahroz Aziz
1   Department of Diagnostic and Interventional Imaging, University of Texas Health Science Center at Houston, Houston, Texas, United States
,
Mohamed Shahin
1   Department of Diagnostic and Interventional Imaging, University of Texas Health Science Center at Houston, Houston, Texas, United States
,
Ammar Almehmi
3   Department of Internal Medicine and Radiology, University of Alabama at Birmingham, Birmingham, Alabama, United States
,
Bridget Kowalczyk
1   Department of Diagnostic and Interventional Imaging, University of Texas Health Science Center at Houston, Houston, Texas, United States
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

Surgical creation of arteriovenous fistulas has been the gold standard for vascular access in hemodialysis patients. However, recent advancements in endovascular technology, the need for alternative hemodialysis access options in nonsurgical candidates, and patient preference for nonsurgical approaches have led to the development of percutaneous arteriovenous fistula creation. Currently, there are two Food and Drug Administration (FDA) approved systems, namely WavelinQ and Ellipsys. The aim of this article is to review the available literature on the outcomes of percutaneous arteriovenous fistula creation. Studies have reported high technical success rates for both the WavelinQ and Ellipsys systems. However, re-interventions were necessary for maturation, maintenance of patency, and treatment of complications. Reported re-intervention rates have varied across studies, device used, and patient populations, ranging from 0.46 to 2.7 per patient-year. While percutaneous arteriovenous fistula creation shows promise in terms of technical success rates, patency, and patient satisfaction, the rate of re-interventions adds to the overall procedural burden and may impact cost-effectiveness.

Keywords

arteriovenous fistula - hemodialysis - WavelinQ - Ellipsys - re-interventions - patency - maturation


Publication History

Article published online:
07 November 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Sgroi MD, Patel MS, Wilson SE, Jennings WC, Blebea J, Huber TS. The optimal initial choice for permanent arteriovenous hemodialysis access. J Vasc Surg 2013; 58 (02) 539-548
    CrossrefPubMedSearch in Google Scholar
  • 2 Hajibandeh S, Burton H, Gleed P, Hajibandeh S, Wilmink T. Impact of arteriovenous fistulas versus arteriovenous grafts on vascular access performance in haemodialysis patients: a systematic review and meta-analysis. Vascular 2022; 30 (06) 1021-1033
    CrossrefPubMedSearch in Google Scholar
  • 3 Fokou M, Teyang A, Ashuntantang G. et al. Complications of arteriovenous fistula for hemodialysis: an 8-year study. Ann Vasc Surg 2012; 26 (05) 680-684
    CrossrefPubMedSearch in Google Scholar
  • 4 See YP, Cho Y, Pascoe EM. et al. Predictors of arteriovenous fistula failure: a post hoc analysis of the FAVOURED study. Kidney360 2020; 1 (11) 1259-1269
    CrossrefPubMedSearch in Google Scholar
  • 5 Al-Jaishi AA, Oliver MJ, Thomas SM. et al. Patency rates of the arteriovenous fistula for hemodialysis: a systematic review and meta-analysis. Am J Kidney Dis 2014; 63 (03) 464-478
    CrossrefPubMedSearch in Google Scholar
  • 6 Chan C, Ochoa CJ, Katz SG. Prognostic factors for arteriovenous fistula maturation. Ann Vasc Surg 2018; 49: 273-276
    CrossrefPubMedSearch in Google Scholar
  • 7 Huber TS, Berceli SA, Scali ST. et al. Arteriovenous fistula maturation, functional patency, and intervention rates. JAMA Surg 2021; 156 (12) 1111-1118
    CrossrefPubMedSearch in Google Scholar
  • 8 Rajan DK, Ebner A, Desai SB, Rios JM, Cohn WE. Percutaneous creation of an arteriovenous fistula for hemodialysis access. J Vasc Interv Radiol 2015; 26 (04) 484-490
    CrossrefPubMedSearch in Google Scholar
  • 9 Mallios A, Jennings WC, Boura B, Costanzo A, Bourquelot P, Combes M. Early results of percutaneous arteriovenous fistula creation with the Ellipsys vascular access system. J Vasc Surg 2018; 68 (04) 1150-1156
    CrossrefPubMedSearch in Google Scholar
  • 10 Nelson PR, Mallios A, Randel M, Jennings WC. Percutaneous arteriovenous fistula creation. Semin Vasc Surg 2021; 34 (04) 195-204
    CrossrefPubMedSearch in Google Scholar
  • 11 Rajan DK, Ahmed O. Percutaneous hemodialysis fistula creation. J Vasc Interv Radiol 2022; 33 (10) 1135-1142.e2
    CrossrefPubMedSearch in Google Scholar
  • 12 Abdel Aal AK, Jefferson X, Klusman C. et al. Devices and techniques for percutaneous creation of dialysis arteriovenous fistulas. Semin Intervent Radiol 2022; 39 (01) 66-74
    Thieme ConnectPubMedSearch in Google Scholar
  • 13 Lok CE, Rajan DK, Clement J. et al; NEAT Investigators. Endovascular proximal forearm arteriovenous fistula for hemodialysis access: results of the prospective, multicenter Novel Endovascular Access Trial (NEAT). Am J Kidney Dis 2017; 70 (04) 486-497
    CrossrefPubMedSearch in Google Scholar
  • 14 Berland TL, Clement J, Griffin J, Westin GG, Ebner A. Endovascular creation of arteriovenous fistulae for hemodialysis access with a 4 Fr device: clinical experience from the EASE study. Ann Vasc Surg 2019; 60: 182-192
    CrossrefPubMedSearch in Google Scholar
  • 15 Berland T, Clement J, Inston N, Kreienberg P, Ouriel K. WavelinQ 4 French Investigators. Percutaneous arteriovenous fistula creation with the 4F WavelinQ EndoAVF system. J Vasc Surg 2022; 75 (03) 1038-1046.e3
    CrossrefPubMedSearch in Google Scholar
  • 16 Hull JE, Elizondo-Riojas G, Bishop W, Voneida-Reyna YL. Thermal resistance anastomosis device for the percutaneous creation of arteriovenous fistulae for hemodialysis. J Vasc Interv Radiol 2017; 28 (03) 380-387
    CrossrefPubMedSearch in Google Scholar
  • 17 Zemela MS, Minami HR, Alvarez AC, Smeds MR. Real-world usage of the WavelinQ EndoAVF system. Ann Vasc Surg 2021; 70: 116-122
    CrossrefPubMedSearch in Google Scholar
  • 18 Hull J, Deitrick J, Groome K. Maturation for hemodialysis in the Ellipsys post-market registry. J Vasc Interv Radiol 2020; 31 (09) 1373-1381
    CrossrefPubMedSearch in Google Scholar
  • 19 Hebibi H, Achiche J, Franco G, Rottembourg J. Clinical hemodialysis experience with percutaneous arteriovenous fistulas created using the Ellipsys® vascular access system. Hemodial Int 2019; 23 (02) 167-172
    CrossrefPubMedSearch in Google Scholar
  • 20 Sultan S, Langsfeld M, Chavez L. et al. Initial 6-month quality review of a percutaneous endovascular arteriovenous fistula program. J Vasc Access 2021; 22 (04) 540-546
    CrossrefPubMedSearch in Google Scholar
  • 21 Hull JE, Jennings WC, Cooper RI, Waheed U, Schaefer ME, Narayan R. The pivotal multicenter trial of ultrasound-guided percutaneous arteriovenous fistula creation for hemodialysis access. J Vasc Interv Radiol 2018; 29 (02) 149-158.e5
    CrossrefPubMedSearch in Google Scholar
  • 22 Mallios A, Bourquelot P, Franco G. et al. Midterm results of percutaneous arteriovenous fistula creation with the Ellipsys vascular access system, technical recommendations, and an algorithm for maintenance. J Vasc Surg 2020; 72 (06) 2097-2106
    CrossrefPubMedSearch in Google Scholar
  • 23 Beathard GA, Litchfield T, Jennings WC. Two-year cumulative patency of endovascular arteriovenous fistula. J Vasc Access 2020; 21 (03) 350-356
    CrossrefPubMedSearch in Google Scholar
  • 24 Yang S, Lok C, Arnold R, Rajan D, Glickman M. Comparison of post-creation procedures and costs between surgical and an endovascular approach to arteriovenous fistula creation. J Vasc Access 2017; 18 (Suppl. 02) 8-14
    CrossrefPubMedSearch in Google Scholar
  • 25 Arnold RJG, Han Y, Balakrishnan R. et al. Comparison between surgical and endovascular hemodialysis arteriovenous fistula interventions and associated costs. J Vasc Interv Radiol 2018; 29 (11) 1558-1566.e2
    CrossrefPubMedSearch in Google Scholar
  • 26 Rognoni C, Tozzi M, Tarricone R. Endovascular versus surgical creation of arteriovenous fistula in hemodialysis patients: cost-effectiveness and budget impact analyses. J Vasc Access 2021; 22 (01) 48-57
    CrossrefPubMedSearch in Google Scholar
  • 27 Mulaney-Topkar B, Ho VT, Sgroi MD, Garcia-Toca M, George EL. Cost-effectiveness analysis of endovascular vs surgical arteriovenous fistula creation in the United States. J Vasc Surg 2024; 79 (02) 366-381.e1
    CrossrefPubMedSearch in Google Scholar
  • 28 Shahverdyan R, Beathard G, Mushtaq N, Litchfield TF, Nelson PR, Jennings WC. Comparison of outcomes of percutaneous arteriovenous fistulae creation by Ellipsys and WavelinQ devices. J Vasc Interv Radiol 2020; 31 (09) 1365-1372
    CrossrefPubMedSearch in Google Scholar